Profil
Valeria Cnossen is currently the Executive Vice President & General Counsel at Galapagos NV.
Prior to her current position, she served as the Head-Legal & Compliance at Crucell NV and as the General Counsel-Consumer Health Group at Johnson & Johnson Consumer NV.
Aktive Positionen von Valeria Cnossen
| Unternehmen | Position | Beginn |
|---|---|---|
| GALAPAGOS NV | General Counsel | 01.01.2023 |
Ehemalige bekannte Positionen von Valeria Cnossen
| Unternehmen | Position | Ende |
|---|---|---|
| Johnson & Johnson Consumer NV | Corporate Officer/Principal | - |
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Compliance Officer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GALAPAGOS NV | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
| Johnson & Johnson Consumer NV |
